Synthesized Heparan Sulfate Competitors Attenuate Pseudomonas aeruginosa Lung Infection

Synthesized Heparan Sulfate Competitors Attenuate Pseudomonas aeruginosa Lung Infection

Several chronic respiratory diseases are characterized by recurrent and/or persistent infections, chronic inflammatory responses and tissue remodeling, including increased levels of glycosaminoglycans which are known structural components of the airways. Among glycosaminoglycans, heparan sulfate (HS...

Full description

Bibliographic Details
Main Authors: Nicola Ivan Lorè, Noemi Veraldi, Camilla Riva, Barbara Sipione, Lorenza Spagnuolo, Ida De Fino, Medede Melessike, Elisa Calzi, Alessandra Bragonzi, Annamaria Naggi, Cristina Cigana
Format: Article
Language:English
Published: MDPI AG 2018-01-01
Series:International Journal of Molecular Sciences
Subjects:
Pseudomonas aeruginosa infections
glycosaminoglycans
anti-inflammatory drugs
mouse models
chronic respiratory diseases
Online Access:http://www.mdpi.com/1422-0067/19/1/207

Internet

http://www.mdpi.com/1422-0067/19/1/207

Similar Items